Stable oncogenic silencing in vivo by programmable and targeted de novo DNA methylation in breast cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Stable oncogenic silencing in vivo by programmable and targeted de novo DNA methylation in breast cancer
Authors
Keywords
-
Journal
ONCOGENE
Volume 34, Issue 43, Pages 5427-5435
Publisher
Springer Nature
Online
2015-02-16
DOI
10.1038/onc.2014.470
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeted Methylation of the Epithelial Cell Adhesion Molecule (EpCAM) Promoter to Silence Its Expression in Ovarian Cancer Cells
- (2014) Suneetha Nunna et al. PLoS One
- Directed Evolution of Improved Zinc Finger Methyltransferases
- (2014) Brian Chaikind et al. PLoS One
- SOX2 Expression Associates with Stem Cell State in Human Ovarian Carcinoma
- (2013) P. M. Bareiss et al. CANCER RESEARCH
- The Epigenetic Modifier Ubiquitin-specific Protease 22 (USP22) Regulates Embryonic Stem Cell Differentiation via Transcriptional Repression of Sex-determining Region Y-box 2 (SOX2)
- (2013) Robyn T. Sussman et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dynamics and Memory of Heterochromatin in Living Cells
- (2012) Nathaniel A. Hathaway et al. CELL
- Cancer epigenomics: beyond genomics
- (2012) Juan Sandoval et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Epigenetic reprogramming of cancer cells via targeted DNA methylation
- (2012) Ashley G. Rivenbark et al. Epigenetics
- Targeting Serous Epithelial Ovarian Cancer with Designer Zinc Finger Transcription Factors
- (2012) Haydee Lara et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeted Methylation and Gene Silencing of VEGF-A in Human Cells by Using a Designed Dnmt3a–Dnmt3L Single-Chain Fusion Protein with Increased DNA Methylation Activity
- (2012) Abu Nasar Siddique et al. JOURNAL OF MOLECULAR BIOLOGY
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- RNA-guided genetic silencing systems in bacteria and archaea
- (2012) Blake Wiedenheft et al. NATURE
- DNA methylation profiling in the clinic: applications and challenges
- (2012) Holger Heyn et al. NATURE REVIEWS GENETICS
- Epigenetic Editing: targeted rewriting of epigenetic marks to modulate expression of selected target genes
- (2012) M. L. de Groote et al. NUCLEIC ACIDS RESEARCH
- Targeted silencing of the oncogenic transcription factor SOX2 in breast cancer
- (2012) Sabine Stolzenburg et al. NUCLEIC ACIDS RESEARCH
- A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
- (2012) M. Jinek et al. SCIENCE
- Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer
- (2011) R Xiang et al. BRITISH JOURNAL OF CANCER
- Silencing chromatin: comparing modes and mechanisms
- (2011) Christian Beisel et al. NATURE REVIEWS GENETICS
- Genetic and Epigenetic Modifications of Sox2 Contribute to the Invasive Phenotype of Malignant Gliomas
- (2011) Marta M. Alonso et al. PLoS One
- TAL Effectors: Customizable Proteins for DNA Targeting
- (2011) A. J. Bogdanove et al. SCIENCE
- What an epigenome remembers
- (2010) Ulrike C. Lange et al. BIOESSAYS
- SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas
- (2009) Adam J Bass et al. NATURE GENETICS
- Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors
- (2009) J. Boch et al. SCIENCE
- The Molecular Mechanism Governing the Oncogenic Potential of SOX2 in Breast Cancer
- (2008) Yupeng Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epigenetic modifications ofSOX2 enhancers, SRR1 and SRR2, correlate with in vitro neural differentiation
- (2008) Marianna Sikorska et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Bivalent domains enforce transcriptional memory of DNA methylated genes in cancer cells
- (2008) J. Rodriguez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started